GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Sales | 3 | 2 | 1 | 20 | 0 |
| Cost of Goods | 0 | 8 | 15 | 25 | N/A |
| Gross Profit | 3 | -6 | -14 | -5 | N/A |
| Operating Expenses | 1,051 | 543 | 482 | 1,878 | 538 |
| Operating Income | -1,048 | -541 | -481 | -1,858 | -527 |
| Interest Expense | 91 | 117 | 180 | 168 | 106 |
| Other Income | 1 | 681 | -1 | 103 | -29 |
| Pre-tax Income | -1,138 | 23 | -662 | -1,923 | -662 |
| Net Income Continuous | -1,138 | 23 | -662 | -1,923 | -662 |
| Net Income | $-1,138 | $23 | $-662 | $-1,923 | $-662 |
| EPS Basic Total Ops | -0.01 | 0.00 | 0.00 | -0.01 | -0.01 |
| EPS Basic Continuous Ops | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| EPS Diluted Total Ops | -0.01 | 0.00 | 0.00 | -0.01 | -0.01 |
| EPS Diluted Continuous Ops | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| EBITDA(a) | $-1,067 | $-481 | $-305 | $-1,768 | $-456 |